Blood and Blood Components Market Overview, Key Growth Factors, and Top Company Analysis

The blood and blood components sector is on track for significant expansion in the coming years. Driven by rising healthcare needs and technological advances, this market is set to witness substantial growth and transformation. Below, we explore the market's expected size, leading players, key trends, and segmentation to provide a comprehensive overview of this critical healthcare industry.

Forecasted Market Size and Growth for the Blood and Blood Components Industry
The blood and blood components market is projected to reach a value of $52.8 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.3%. This positive trajectory is mainly fueled by the rising burden of chronic diseases, supportive government programs, and increasing demand for whole blood. Key developments anticipated during this period include enhanced collaboration among industry stakeholders, the launch of innovative medical products, intensified research and development efforts, adoption of IoT-based technologies to reduce contamination risks, and improved management practices for blood transfusion procedures.

Download a free sample of the blood and blood components market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2573&type=smp

Noteworthy Companies Driving the Blood and Blood Components Market
Several prominent organizations play a pivotal role in this market, including the American Red Cross, The Japanese Red Cross Society, Canadian Blood Services, Australian Red Cross, and Vitalant. Other significant participants consist of SANQUIN BLOOD SUPPLY FOUNDATION, New York Blood Center, Blood Bank of Alaska, Blood Centers of America, Xinjiang Deyuan Bioengineering, Harbin Pacific Biopharmaceutical, Beijing Tiantan Biological Products, Shanghai RAAS Blood Products, China Biologic Products, and Hualan Biological Engineering. Additional key players include Biotest AG, Lorne Laboratories UK, LMB Germany, Bio Products Laboratory Ltd, Clinical Trials Laboratory Services (CTLS), Roche, Hemanext Inc, Kedrion Biopharma, KalVista Pharmaceuticals, Personal Genome, Cellphire, Inc., Immuno-Mycologics INC, CSL Behring, Nordson Corporation, Octapharma Canada Inc., Abbott Laboratories, Grifols, Nipro Medical Corporation, and Becton, dic*kinson and Company.

A notable event in this space occurred in October 2022 when Pfizer, the US-based pharmaceutical giant, acquired Global Blood Therapeutics for an undisclosed sum. This strategic move strengthens Pfizer's position in addressing sickle cell disease and builds upon its 30-year history in blood-related therapies. Global Blood Therapeutics specializes in developing treatments aimed specifically at blood disorders, with a focus on sickle cell disease.

View the full blood and blood components market report:
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Emerging Collaboration Trends in the Blood and Blood Components Industry
A defining trend in the blood and blood components market is the growing emphasis on partnerships among various players. Companies are increasingly joining forces to broaden their market reach, build customer awareness, and enhance service delivery. For instance, the American Red Cross partnered with HealthStream to roll out a new program tailored for healthcare providers. Similarly, the Blood Center of Wisconsin teamed up with SysLogic Inc. to explore how RFID technology can improve patient safety during blood collection and transfusion processes.

Innovations and Strategic Alliances Fueling Market Progress
These collaborative efforts are complemented by a push toward technological integration and innovation, aiming to make blood management safer and more efficient. Such strategic alliances not only promote knowledge sharing but also accelerate the adoption of cutting-edge solutions to meet evolving healthcare demands.

Detailed Market Segmentation for Blood and Blood Components
The blood and blood components market is segmented across several categories:
1) By Product Type: Whole Blood and Blood Components
2) By Blood Components: Red Blood Cells, Platelets, Plasma, and White Blood Cells
3) By End-User: Hospitals, Ambulatory Surgical Centers, and Other Healthcare Facilities
4) By Application Area: Anemia, Trauma and Surgery, Cancer Treatment, and Bleeding Disorders

Further subcategories break down Whole Blood into Donor Whole Blood and Autologous Whole Blood, while Blood Components are dissected into Red Blood Cells, Platelets, Plasma, and White Blood Cells. This detailed classification helps stakeholders better understand the market dynamics and target specific areas for development and investment.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.